Medical Device Network on MSN
GE HealthCare advances Signa MRI portfolio with trio of FDA clearances
The FDA clearance of GE HealthCare’s next-generation Signa products aligns with the company’s multi-year strategy to differentiate its MRI portfolio.
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI technology ...
SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in ...
(RTTNews) - GE HealthCare (GEHC) announced the submission of its next-generation SIGNA™ MRI technology to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. The new systems are designed ...
Zacks Investment Research on MSN
GE HealthCare wins FDA clearances for next-gen SIGNA MRI portfolio
GE HealthCare Technologies Inc. GEHC recently announced FDA 510(k) clearance for three new magnetic resonance (MR) innovations — SIGNA Sprint with Freelium, a 1.5T sealed magnet MRI system; SIGNA Bolt ...
GE HealthCare GEHC recently unveiled its next-generation SIGNA MRI portfolio, the 3T SIGNA Bolt and 1.5T SIGNA Sprint with Freelium, aimed at boosting efficiency, advancing precision diagnostics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results